Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Mallinckrodt
AstraZeneca
Merck
Harvard Business School

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Patent: 7,214,381

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,214,381
Title:Composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
Abstract: The present invention refers to a pharmaceutical composition suitable for the transdermal or transmucosal administration of one or more active agents, in form of a gel or a solution, comprising as a permeation enhancers a combination of: a) saturated fatty alcohol of formula CH.sub.3--(CH.sub.2).sub.n--CH.sub.2OH or saturated fatty acid CH.sub.3--(CH.sub.2).sub.n--CH.sub.2COOH wherein n is an integer number 8/22, preferably 8/12, most preferably 10, or unsaturated fatty alcohol or fatty acid of formula: CH.sub.3(C.sub.nH.sub.2(n-1))--OH or CH.sub.3(C.sub.nH.sub.2(n-1))--COOH wherein n is an integer number 8/22, b) a ternary vehicle or carrier consisting of a C.sub.1/C.sub.4 alkanol, a polyalcohol in particular propylenglycol and water, c) optionally also a monoalkylether of diethylenglycol.
Inventor(s): Carrara; Dario (Buenos Aires, AR), Porto; Gabriel (Basel, CH), Rodriguez; Jorge (Buenos Aires, AR)
Assignee: Antares Pharma IPL AG (Zug, CH)
Application Number:10/343,570
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,214,381
Patent Claims:see list of patent claims

Details for Patent 7,214,381

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23   Start Trial Antares Pharma IPL AG (Zug, CH) 2020-08-03 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23   Start Trial Antares Pharma IPL AG (Zug, CH) 2020-08-03 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23   Start Trial Antares Pharma IPL AG (Zug, CH) 2020-08-03 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Merck
Johnson and Johnson
Mallinckrodt
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.